Recolony identified as one of the 15 most promising Swiss biotech startups of 2023, according to investors
26-09-2023 – Recolony has been identified as one of the 15 most promising Swiss biotech startups of 2023, according to investors.
The annual ranking of the TOP 100 Swiss Startups has become a benchmark in Switzerland’s startup ecosystem—and beyond. Every year, a panel of 100 leading investors and startup experts chooses the 100 most innovative and promising Swiss startups. Discover the 15 biotech startups that impressed the TOP 100 Jury and the public the most with their innovative solutions.
